An agent comprising a protein complex comprising an oligomeric form of alpha -lactalbumin (MAL) and a further reagent which is combined with MAL such that it is carried into the nucleoplasm of cells which are susceptible to MAL. Agents of this type, where the further reagent is a therapeutic or labelling reagent, can be used in diagnosis and therapy in particular of cancer.
